5% STAKE520A.TTSE GROWTH

Newton Biocapital I, pricaf privee de droit belge discloses 6.87% stake in J-Pharma

Summary

Newton Biocapital I, pricaf privee de droit belge filed a New 5%+ stake (large shareholding report) via EDINET on 2026-03-26 11:24 JST concerning J-Pharma Co., Ltd. Reported holding ratio: 6.87%.

Open the price chart on TradingView.

Source: EDINET S100XTZW ↗ · PDL1.0 · Not investment advice